Review Article
History of endoscopic submucosal dissection and role for colorectal endoscopic
submucosal dissection: A Japanese perspective
Masakatsu Fukuzawa
*, Takuji Gotoda
a b s t r a c t
Endoscopic resection of early gastric cancer is a well-established standard therapy in Japan, and is increasingly used in other countries. The development of endoscopic submucosal dissection (ESD) for early gastric cancer provides en bloc R0 specimen, regardless of size and/or location. On the other hand, for many years, conventional endoscopic mucosal resection and surgery were the only available treatments for large colorectal tumors, including laterally spreading tumors. Recently, ESD has also been increasingly applied to the colon and rectum. However, ESD has not yet been fully established as a standard therapeutic method for colorectal lesions because of its technical difficulty and complications, such as perforation and longer procedure time than the conventional endoscopic mucosal resection. In this report, we provide an overview of the indications for colorectal ESD and presented clinical outcome, regarding the safety and efficacy in our hospital with a review of the published works.
CopyrightÓ 2012, Society of Gastrointestinal Intervention. Published by Elsevier. All rights reserved. Keywords: Early colorectal cancer, Endoscopic submucosal dissection, Lower gastrointestinal tract
Introduction
Endoscopic submucosal dissection (ESD) was initially developed for the treatment of early gastric cancer to facilitate en bloc resection of large superficial tumors.1–5The primary purpose of ESD is to decrease the risk of local cancer recurrence, by performing en bloc resection and providing an accurate histopathological diagnosis. ESD is widely used for the treatment of carcinoma of the early gastric and esophageal carcinoma in Japan.6–10National health insurance covers the expense of ESD, as a therapeutic procedure, for early gastric and esophageal carcinoma. However, ESD has not yet been recognized as a standard therapeutic procedure for early colorectal carcinoma because of its technical difficulty with the risk of complications, such as perforation and bleeding and its longer procedure time. More recently, with the development of various new instruments,11–15the increased effectiveness of colorectal ESD has been reported.16–25The number of medical facilities that perform colorectal ESD has also been increasing recently in the West.26–28
This review focuses on the process of development of the upper gastrointestinal (GI) ESD, an indication for lower GI ESD, and several differences between Japan and Western countries in performing ESD for the lower GI lesions.
History of endoscopic treatment for GI tumors
Endoscopic resection to treat cancer is perhaps the most grati-fying endoscopic procedure to perform because of its minimal
invasiveness and curative potential. Endoscopic resection of early gastric cancer (EGC) is a standard therapeutic choice in Japan and is increasingly used globally.29,30 Endoscopic resection offers mini-mally invasive treatment at a lower cost, but with comparable efficacy to surgery. It allows complete pathological staging of the cancer, which is critical for risk stratification of metastatic poten-tial.31 Patients who are stratified to have no or lower risk for developing lymph node metastasis than the risk of mortality from surgery are ideal candidates for endoscopic resection.32
Thefirst endoscopic resection of early cancer was reported in colorectal polypectomy, using high-frequency electric surgical unit.33 Indeed, thefirst endoscopic polypectomy used to treat pedunculated or semipedunculated EGC wasfirst described in Japan, during the year 1974. The“strip biopsy” technique, an early method of endo-scopic mucosal resection (EMR) technique, was devised in 1984 as an application of endoscopic snare polypectomy.34 For this method, a double channel endoscope is used in order to snare the early cancer, while it is being pulled toward the endoscope with a grasper. The technique was designed for resection of small lesions with a surrounding normal margin, thus allowing a proper pathological assessment. To ensure that the snare captures the entire lesion with a 5-mm surrounding normal margin, in 1988, a technique called ERHSE (endoscopic resection with local injection of hypertonic saline epinephrine solution) was developed by Hirao and colleagues.35The technique is composed of performing a snare resection of a cancer with a normal margin,35 which has been isolated with normal surrounding mucosa, by circumferential incision into the Department of Gastroentelorogy and Hepatology, Tokyo Medical University, Tokyo, Japan
Received 7 July 2012; Revised 7 July 2012; Accepted 7 July 2012
* Corresponding author. Department of Gastroentelorogy and Hepatology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjukuku, Tokyo 160-0023, Japan. E-mail address:masakatu8055@yahoo.co.jp(M. Fukuzawa).
Contents lists available atSciVerse ScienceDirect
Gastrointestinal Intervention
j o u r n a l h o m e p a g e : w w w . g i - i n t e r v e n t i o n . o r g2213-1795/$– see front matter Copyright Ó 2012, Society of Gastrointestinal Intervention. Published by Elsevier. All rights reserved.
http://dx.doi.org/10.1016/j.gii.2012.09.001
submucosa, thus ensuring en bloc R0 resection. In this technique, after injection of hypertonic saline and diluted epinephrine, the periphery of the lesion was incised using a needle knife, and the lesion was removed using a snare. Unfortunately, this rather amazing technique required considerable skills to perform given the risks of perforation from using the needle knife.
EMR with cap-fitted panendoscope method (EMRC) was developed in 1992 for the resection of early esophageal cancer and directly applicable for the resection of EGC.36The technique uses a transparent plastic cap, which is mounted to the tip of a standard endoscope. A specialized snare is prelooped inside the groove of the inner aspect in the distal part of the cap, thus allowing its use to cut the lesions that are suctioned into the cap. The EMR technique using ligation, which was subsequently extended to EMR using multiband ligation (EMR-L/EMR-MBL), utilizes band ligation to create a“pseudopolyp” by suctioning the lesion into the banding cap and deploying a band underneath it.37,38The EMRC and EMR-L/ EMR-MBL technique have the advantage of being relatively simple. These techniques require the use of a standard endoscope, without any additional equipment or assistant. However, these techniques cannot be used to remove the lesions en bloc larger than 2 cm.39,40 Piecemeal resections in lesions larger than 2 cm leads to a high risk for local cancer recurrence and inadequate pathological staging.41 Therefore, methods to remove large lesions en bloc were developed.42
Development of ESD for EGC
The Insulated-tip diathermic knife (IT-knife) was devised in late 1990s at the National Cancer Center Hospital Japan, in order to resolve the problems observed during the EMR and ERHSE tech-niques for the resection of EGC. The knife has a ceramic ball tip, thus preventing it from puncturing the wall during the application of cautery and causing perforation. The knife can also be used to dissect the submucosa, which leads to the name of the techni-quedESD technique.1,3,11Subsequent studies have proven that ESD, using a standard single-channel endoscope, can be used for the resection of large lesions en bloc, allowing for a precise pathological staging.
With the development of ESD, the indication criteria for endo-scopic resection were revised. The empirical indications for EMR were therefore: (1) papillary or tubular (differentiated) adenocar-cinoma, (2) less than 2 cm in diameter, (3) without ulceration within tumor, and (4) no lymphatics or vessels involvement.43 Clinical observations have noted that the empirical indications for EMR are too strict and lead to unnecessary surgery. Therefore, expanded criteria for endoscopic resection have been proposed, especially after large en bloc resection could be accomplished using ESD.44,45Long-term survival and outcomes studies also showed that ESD patients who have the treatment following the expanded criteria are similar to those who have the treatment following the guideline criteria.46 Other ESD knives6–10 and techniques have since been developed and studied in detail. Within less than a decade, ESD has become the standard of treatment for resection of EGC in Japan.
Conventional EMR for lower GI tumors
Recently, ESD has also been increasingly applied to the colon and rectum (Fig. 1A–D). Many studies by Japanese endoscopists have reported that colorectal ESD can overcome the technical limitation of EMR and achieve higher en bloc resection rate16–23 with the development of various new devices.11–14However, this procedure is known to have several disadvantages compared to conventional colorectal EMR: greater technical difficulty, longer
procedure time, and increased risk of complications, including perforation and bleeding.
EMR is indicated for the treatment of superficial, early-stage colorectal cancer because of its minimal invasiveness and excel-lent results in terms of clinical outcomes.33,47 However, conven-tional EMR techniques currently used for the resection of laterally spreading tumors (LSTs)48–51are inadequate for the en bloc resec-tion of flat lesions 20 mm because of incomplete removal and problems with local recurrence.52 Conventional EMRs usually resulted in endoscopic piecemeal mucosal resection (EPMR), particularly for large LSTs20 mm with reports of local recurrence rates, ranging from 7.4% to 17%.49,52,53Most of those recurrences, however, received repeated endoscopic treatment with excellent results in terms of the preservation of the colorectum. But only a few cases required surgery after EPMRs in the long-term follow-up study.20Those cases may originally have had either submucosal invasion or lymphatic invasion that was not diagnosed histologi-cally because of the increased difficulty in assessing a piecemeal resection.
Indications for lower GI ESD
Colonic LSTs are good candidates for endoscopic treatment, because they extend laterally rather than vertically. Based on clin-icopathological analysis of LSTs, LST nongranular type (LST-NG) has a higher rate of submucosal invasion, and diagnosis of tumor depth is more difficult to make endoscopically compared to LST granular type (LST-G).51LST-G showing adenoma or focal cancer in adenoma is an indication for EPMR under the condition that the cancerous portion is perfectly resected en bloc. Observation of the pit pattern54–56 with a magnifying endoscope is essential before piecemeal EMR. Endoscopic treatment is indicated for the adenoma and intramucosal or submucosal superficial (sm1: less than 1000
m
m from the muscularis mucosae) colorectal cancer because of its minimal invasiveness and negligible risk of lymph-node metastasis.57In our hospital, we performed preoperative endoscopy and examined the lesion under magnifying chromoendoscopy for all cases. Then, we diagnosed the depth of the lesion and determined the most appropriate procedure. An invasive pattern was considered a contraindication for ESD.55,56 The existence of a noninvasive pattern, as determined by magnification chromoendoscopy, was the minimum requirement for all lesions that were candidates for ESD and EMR. When a lesion was detected by conventional endoscopic examination, surface mucous was washed away with lukewarm water that contained pronase (Pronase MS; Kaken Pharmaceutical Co., Ltd., Tokyo, Japan), and then 0.4% indigo-carmine dye was sprayed over the lesion to enhance its surface detail. High-magnification colonoscopes (CF-H260AZI, CF-FH260AZI, and PCF-Q260AZI; Olympus Optical Co., Ltd., Tokyo, Japan) were used to evaluate the surface character to differentiate an invasive pattern from a noninvasive pattern. The invasive pattern is characterized by irregular and distorted epithelial crests, observed in a demarcated area, suggesting that sm invasion is>1000
m
m, while a noninvasive pattern does not have this finding, which suggests intramucosal neoplasia or sm invasion <1000m
m. When high-magnification observation with indigo-carmine dye was insufficient to deter-mine the surface structure, we performed staining with 0.05% crystal violet. Based on extensive clinicopathological analyses, we defined the indications for ESD.In our institution, the indications for colorectal ESD are lesion size more than 20 mm for LST-NG or more than 30 mm for LST-G. An LST-G 20–30 mm can be treated by planned EPMR, rather than ESD with the area, including the largest nodule resectedfirst followed by the remaining tumor. Mucosal lesions with
Fig. 1. Endoscopic submucosal dissection for a 30 mm laterally spreading tumor nongranular (LST-NG) type with scar after endoscopic mucosal resection located in the transverse colon. (A-1) Conventional colonoscopy image. (A-2) Conventional colonoscopy image following 0.4% indigo-carmine dye spraying. (B) Magnified view revealing a non-invasive pattern. (C-1) An injection solution was injected into the submucosal layer to lift the lesion. (C-2) Submucosal layer withfibrosis. (C-3) After ESD view. (D-1) Histological image, in the part of black box is submucosal invasion (HE staining). (D-2) Histological diagnosis; well-differentiated adenocarcinoma (tub1), pSM (50mm), ly0, v0, pHM0, pVM0.
Gastrointestinal Intervention 2012 1(1), 30–35 32
fibrosisdcaused by biopsy or local residual or recurrent colorectal adenoma or early carcinoma after endoscopic resection, which is difficult to resect by conventional EMRdwere considered appro-priate for colorectal ESD. Similar indications for colorectal ESD, recommended by the Colorectal ESD Standardization Imple-mentation Working Group, are as follows (Table 1)58: (1) lesions difficult to remove en bloc with a snare EMR due to size, such as nongranular LST (particularly pseudo-depressed type), lesions showing a type Vi pit pattern in Kudo’s classification and protruded-type large lesions suspected to be carcinoma; (2) lesions with fibrosis due to biopsy or peristalsis; (3) sporadic localized lesions in chronic inflammation, such as ulcerative colitis; and (4) local residual carcinoma after EMR. However, ESD for lesions with severefibrosis is technically very difficult. To select the best therapy (piecemeal EMR, ESD, or surgical resection) in practice, we should consider not only the clinicopathological features of the lesions and location, but also the skill level of the colonoscopist, including the ability in scope handling and the predicted procedure time.
In April 2012, colorectal ESD for the lower GI neoplasm (adenoma/cancer) was recognized as a clinical practice provided by the Japanese national health insurance. The indications for colo-rectal ESD under this system are defined as colorectal adenoma/ early colorectal carcinoma of more than 20 mm and less than 50 mm, which are difficult to resect en bloc by conventional EMR. Lower GI ESD procedure
The primary purpose of ESD is to decrease the risk of local cancer recurrence by performing en bloc R0 resection and to provide a complete pathological specimen. ESD techniques are
available using various knives.11–15 A standard single channel gastroscope is usually used for ESD. When the lesions are located at the rectum or proximal colon, Q260J endoscope (Olympus Optical) is mostly used. For the lesions located at the distal colon, PCF-Q260JI endoscope (Olympus Optical) is used. Injection solutions are glycerol and sodium hyaluronate with small amounts of indigo carmine. Indigo carmine is added to the submucosal injectionfluid in order to make a better identifiable blue-colored submucosal layer. It has been recently reported that the use of sodium hyalur-onate (MucoUp; Johnson & Johnson, Tokyo, Japan) for submucosal injection provides a longer-lasting submucosal cushion, helping to prevent perforation and make the ESD procedures technically easier and safer.59After the submucosal injection, a circumferential incision in the mucosa was made with cutting devices atfirst. The procedures were primarily performed using a bipolar needle knife (B- knife) (XEMEX Co., Tokyo, Japan)or a monopolar knife (Dual knife, IT knife-2) (Olympus Co., Tokyo, Japan) in our hospital (Fig. 2A, B). The B-Knife were used with the following setting; 50 W, effect 3, Endo-Cut mode, and 30 W, effect 3, Forced coagulation mode with ICC200. The Dual Knife were used with the following setting: 30 W, effect 3, Endo Cut mode, and 30 W, effect 3, Forced coagulation mode with ICC200. Injection solution was then injected into the submucosal layer to lift the lesion, and the thickened submucosal layer was cut with the same knives. Attachment hood is used in all procedures. A soft transparent hood (JMDN 38819001; Top Corp., Tokyo, Japan) is mounted at the distal end of the gastroscope in order to optimize the visualization of the operating field in the submucosal space and to create countertraction for exfoliating the submucosal tissue. A small-caliber-tip transparent hood (ST hood; Fujifilm Co., Ltd., Tokyo, Japan) is also useful to lift the incised submucosal tissue and stabilize the submucosal dissection.60Conscious sedation by intravenous injection of mid-azolam (2 mg) was used before the insertion of colonoscope. In addition, 2 mg was given repeatedly, based on the endoscopist’s judgment. In all cases, we used a high-frequency generator unit ICC200 (Erbe Elejtromedizim, Tübingen, Germany) and a carbon dioxide (CO2) insufflation system, which is essential for reducing
abdominal discomfort.61,62 Clinical outcome of lower GI ESD
We searched PubMed database for publications until July 2012, related to colorectal ESD, using the key words, ESD and colon. The MEDLINE database was also used to search for publications through July 2012 related to ESD, using the above-mentioned keywords. A manual search of the citations of relevant articles was also performed. Table 1 Indication of Endoscopic Submucosal Dissection (ESD) for Colorectal
Tumor by Colorectal ESD Standardization Implementation Working Group 1. Large sized (>20 mm in diameter) lesions in which en bloc
resectiom using snare EMR is difficult, although it is indicative for endoscopic treatment
LST-NG,particularly those of the pseudo-depressed type Lesions showing VI type pit pattern in kudo’s classification Carcinoma with submucosal infiltration
Large depressed type lesion
Large elevated lesion suspected to be carcinoma
2. Mucosal lesions withfibrosis caused by prolapse due to biopsy or peristalsis of the lesions
3. Sporadic localized tumors in chronic inflammation such as ulcerative colitis
4. Local residual early carcinoma after endoscopic resection
Including granular-type laterally spreading tumors (LST-G), nodular mixed type. EMR, endoscopic mucosal resection.
Pertinent studies published in English and Japanese were reviewed. If an institution had published several reports on colorectal ESD, the newest report was selected for the summary of outcomes of colorectal ESD. A clinical outcome of colorectal ESD in large series (>100) about the previous reports and our hospital is described in Table 2. Regarding efficacy, the en bloc resection (endoscopic) and complete en bloc resection (histological) rates were 90.1% (86–98.2%, 2264/2491) and 81.1% (74.5–86%, 1115/1375), respectively. Regarding complica-tions, the perforation and late bleeding rates were 4.5% (1.8– 8.2%,122/ 2694) and 1.3% (0.5–2.4%, 31/2371), respectively. Local recurrence was detected in 1.1% (0–2%, 9/768) of cases.
Lower GI ESD in Western countries
Several reports were published from Western countries con-cerning colorectal ESD26–28; however, compared to Japan it is infrequently performed in Western countries. Uraoka et al reported that there are several differences between practices in Japan and Western countries. At first, according to the measurement of colonic length of Asian and Caucasian patients, the colonic length of Caucasian patients was significantly longer.63In the clinical setting,
short-type (1.3 m) colonoscopes are regularly used in Japan, whereas in most Western countries, long (1.7 m) colonoscopies are used. Therefore, a more difficult colonic anatomy and the frequent need for longer colonoscopes would support the possibility that colonoscopy and related therapeutic procedures are more complex in Western patients. Second, Western endoscopists prefer to use propofol for sedation during colonoscopy. If the position of the patient is not going to be changed during colonoscopy, then stronger sedation can be used. However, taking advantage of gravitation during colonoscopy is useful, as the submucosal dissection plane can be observed more clearly in certain patient positions, in which the partially dissected lesion is pulled down by its own weight. Patient rotation can be used by Japanese endo-scopists during colorectal ESD, because they do not apply deep sedation to their patients. One of the main limitations to the implementation of ESD in Western countries is that, compared to Japan, there are very few institutions with enough expertise in colorectal ESD to become training centers. However, in Japan, a significant number of endoscopists have experience, at a minimum, in more than 50 colorectal ESD cases.64Furthermore, development of various devices, specialized in each part of the digestive tract, was regarded as the major factor why the ESD procedure is widely practiced in Japan. Performing ESD in a clinical setting with appropriate professional guidance and supervision also is an important consideration in terms of the learning curve, at least in the early phases of actual clinical experience.
In the future, establishment of a training system for colorectal ESD, based on clinical outcomes and the learning curves for trainees,19,65 is necessary to standardize training and achieve wider acceptance of the technique.66
Disclosure
All authors disclosed nofinancial relationships relevant to this publication.
Conflict of interest
The author declares that there is no conflict of interest.
References
1. Hosokawa K, Yoshida S. Recent advances in endoscopic mucosal resection for early gastric cancer. Gan To Kagaku Ryoho. 1998;25:476–83. [in Japanese with English abstract]
2. Ohkuwa M, Hosokawa K, Boku N, Ohtu A, Tajiri H, Yoshida S. New endoscopic treatment for intramucosal gastric tumors using an insulated-tip diathermic knife. Endoscopy. 2001;33:221–6.
3. Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, Saito D, et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut. 2001;48:225–9. 4. Kondo H, Gotoda T, Ono H, Oda I, Kozu T, Fujishiro M, et al. Percutaneous
traction-assisted EMR by using an insulation-tipped electrosurgical knife for early stage gastric cancer. Gastrointest Endosc. 2004;59:284–8.
5. Gotoda T. A large endoscopic resection by endoscopic submucosal dissection procedure for early gastric cancer. Clin Gastroenterol Hepatol. 2005;3:S71–3. 6. Oyama T, Kikuchi Y. Aggressive endoscopic mucosal resection in the upper GI
tract– Hook knife EMR method. Min Invas Ther Allied Technol. 2002;11:291–5. 7. Yahagi N, Fujishiro M, Kakushima N, Kobayashi K, Hashimoto T, Oka M, et al. Endoscopic submucosal dissection for early gastric cancer using the tip of an electrosurgical snare (thin type). Dig Endosc. 2004;16:34–8.
8. Ono H, Hasuike N, Inui T, Takizawa K, Ikehara H, Yamaguchi Y, et al. Usefulness of a novel electrosurgical knife, the insulation-tipped diathermic knife-2, for endoscopic submucosal dissection of early gastric cancer. Gastric Cancer. 2008; 11:47–52.
9. Takeuchi Y, Uedo N, Ishihara R, Iishi H, Kizu T, Inoue T, et al. Efficacy of an endo-knife with a water-jet function (Flushendo-knife) for endoscopic submucosal dissec-tion of superficial colorectal neoplasms. Am J Gastroenterol. 2010;105:314–22. 10. Toyonaga T, Man-I M, Fujita T, Nishino E, Ono W, Morita Y, et al. The
perfor-mance of a novel ball-tipped Flush knife for endoscopic submucosal dissection: a case-control study. Aliment Pharmacol Ther. 2010;32:908–15.
11. Gotoda T, Kondo H, Ono H, Saito Y, Yamaguchi H, Saito D, et al. A new endoscopic mucosal resection procedure using an insulation-tipped elec-trosurgical knife for rectal flat lesions: report of two cases. Gastrointest Endosc. 1999;50:560–3.
12. Kodashima S, Fujishiro M, Yahagi N, Kakushima N, Omata M. Endoscopic submucosal dissection usingflexknife. J Clin Gastroenterol. 2006;40:378–84. 13. Sano Y, Fu KI, Saito Y, Doi T, Hanafusa M, Fujii S, et al. A newly developed
bipolar-current needle-knife for endoscopic submucosal dissection of large colorectal tumors. Endoscopy. 2006;38:E95.
14. Hotta K, Oyama T, Miyata Y, Tomori A, Takahashi A, Saito Y, et al. Techniques for and challenges with endoscopic submucosal dissection methods employing Hook knife for colorectal neoplasms. Early Colorectal Cancer. 2006;10:501–5. [in Japanese with English abstract]
15. Homma K, Otaki Y, Sugawara M, Kobayashi M. Efficacy of novel SB knife Jr examined in a multicenter study on colorectal endoscopic submucosal dissection. Dig Endosc. 2012;24:117–20.
16. Yamamoto H. Endoscopic submucosal dissection of early cancers and large flat adenomas. Clin Gastroenterol Hepatol. 2005;3:S74–6.
17. Isomoto H, Nishiyama H, Yamaguchi N, Fukuda E, Ishii H, Ikeda K, et al. Clin-icopathological factors associated with clinical outcomes of endoscopic submucosal dissection for colorectal epithelial neoplasms. Endoscopy. 2009;41: 679–83.
Table 2 A Clinical Outcome of Colorectal Endoscopic Submucosal Dissection (ESD) in Large Series (>100) from Previous Reports and in Our Hospital Authors (y) No.
of cases Size (mm) En bloc resection rate (%) Complete en bloc resection rate (%) Complication Local recurrence(%) Perforation (%) Bleeding (%) Isomoto (2009)17 292 26.8 263/292 (90.1%) 233/292 (79.8%) 23/292 (8.2%) 2/292 (0.7%) 1/220 (0.5%) Saito (2009)18 405 40 352/405 (87%) – 14/405 (3.5%) 4/405 (1.0%) – Hotta (2010)19 120 35 112/120 (93.3%) 102/120 (85%) 9/120 (7.5%) – – Niimi (2010)20 310 28.9 280/310 (90.3%) 231/310 (74.5%) 15/310 (4.8%) 5/310 (1.6%) 4/202 (2.0%) Yoshida (2010)21 250 29.1 217/250 (86.8%) 203/250 (81.2%) 15/250 (6%) 6/250 (2.4%) – Toyonaga (2010)22 512 29 503/512 (98.2%) – 9/512 (1.8%) 8/512 (1.6%) – Matsumoto (2010)23 203 32.4 – 174/203 (85.7%) 14/203 (6.9%) – – Uraoka (2011)24 202 39.9 185/202 (91.6%) – 5/202 (2.5%) 1/202 (0.5%) 0/165 (0%) Hisabe (2012)25 200 32.7 172/200 (86%) – 14/200 (7.0%) 2/200 (1.0%) – Fukuzawa (2012) 200 34.6 180/200 (90%) 172/200 (86%) 4/200 (2%) 3/200 (1.5%) 4/200 (2%) Gastrointestinal Intervention 2012 1(1), 30–35 34
18. Saito Y, Sakamoto T, Fukunaga S, Nakajima T, Kiriyama S, Matsuda T. Endo-scopic submucosal dissection (ESD) for colorectal tumors. Dig Endosc. 2009;21: S7–12.
19. Hotta K, Oyama T, Shinohara T, Miyata Y, Takahashi A, Kitamura Y, et al. Learning curve for endoscopic submucosal dissection of large colorectal tumors. Dig Endosc. 2010;22:302–6.
20. Niimi K, Fujishiro M, Kodashima S, Goto O, Ono S, Hirano K, et al. Long-term outcomes of endoscopic submucosal dissection for colorectal epithelial neoplasms. Endoscopy. 2010;42:723–9.
21. Yoshida N, Naito Y, Kugai M, Inoue K, Wakabayashi N, Yagi N, et al. Efficient hemostatic method for endoscopic submucosal dissection of colorectal tumors. World J Gastroenterol. 2010;16:4180–6.
22. Toyonaga T, Man-i M, Chinzei R, Takada N, Iwata Y, Morita Y, et al. Endoscopic treatment for early stage colorectal tumors: the comparison between EMR with small incision, simplified ESD, and ESD using the standard flush knife and the ball tippedflush knife. Acta Chir Iugosl. 2010;57:41–6.
23. Matsumoto A, Tanaka S, Oba S, Kanao H, Oka S, Yoshihara M, et al. Outcome of endoscopic submucosal dissection for colorectal tumors accompanied by fibrosis. Scand J Gastroenterol. 2010;45:1329–37.
24. Uraoka T, Higashi R, Kato J, Kaji E, Suzuki H, Ishikawa S, et al. Colorectal endoscopic submucosal dissection for elderly patients at least 80 years of age. Surg Endosc. 2011;25:3000–7.
25. Hisabe T, Nagahama T, Hirai F, Matsui T, Iwashita A. Clinical outcomes of 200 colorectal endoscopic submucosal dissections. Dig Endosc. 2012;24:105–9. 26. Repici A, Hassan C, De Paula Pessoa D, Pagano N, Arezzo A, Zullo A, et al.
Efficacy and safety of endoscopic submucosal dissection for colorectal neoplasia: a systematic review. Endoscopy. 2012;44:137–50.
27. Antillon MR, Bartalos CR, Miller ML, Diaz-Arias AA, Ibdah JA, Marshall JB. En bloc endoscopic submucosal dissection of a 14-cm laterally spreading adenoma of the rectum with involvement to the anal canal: expanding the frontiers of endoscopic surgery (with video). Gastrointest Endosc. 2008;67:332–7. 28. Hurlstone DP, Atkinson R, Sanders DS, Thomson M, Cross SS, Brown S.
Achieving R0 resection in the colorectum using endoscopic submucosal dissection. Br J Surg. 2007;94:1536–42.
29. Rembacken BJ, Gotoda T, Fujii T, Axon AT. Endoscopic mucosal resection. Endoscopy. 2001;33:709–18.
30. Soetikno RM, Gotoda T, Nakanishi Y, Soehendra N. Endoscopic mucosal resection. Gastrointest Endosc. 2003;57:567–79.
31. Hull MJ, Mino-Kenudson M, Nishioka NS, Ban S, Sepehr A, Puricelli W, et al. Endoscopic mucosal resection: an improved diagnostic procedure for early gastroesophageal epithelial neoplasms. Am J Surg Pathol. 2006;30:114–8. 32. Ludwig K, Klautke G, Bernhard J, Weiner R. Minimally invasive and local
treatment for mucosal early gastric cancer. Surg Endosc. 2005;19:1362–6. 33. Deyhle P, Largiader F, Jenny S, Fumagalli I. A method for endoscopic
electroresection of sessile colonic polyps. Endoscopy. 1973;5:38–40. 34. Tada M, Murata M, Murakami F. Development of strip-off biopsy. Gastroenterol
Endosc. 1984;26:833–9. [in Japanese with English abstract]
35. Hirao M, Masuda K, Asanuma T, Naka H, Noda K, Matsuura K, et al. Endoscopic resection of early gastric cancer and other tumors with local injection of hypertonic saline-epinephrine. Gastrointest Endosc. 1988;34:264–9. 36. Inoue H, Endo M, Takeshita K, Yoshino K, Muraoka Y, Yoneshima H. A new
simplified technique of endoscopic esophageal mucosal resection using a cap-fitted panendoscope (EMRC). Surg Endosc. 1992;6:264–5.
37. Akiyama M, Ota M, Nakajima H, Yamagata K, Munakata A. Endoscopic mucosal resection of gastric neoplasms using a ligating device. Gastrointest Endosc. 1997;45:182–6.
38. Soehendra N, Seewald S, Groth S, Omar S, Seitz U, Zhong Y, et al. Use of modified multiband ligator facilitates circumferential EMR in Barrett’s esoph-agus (with video). Gastrointest Endosc. 2006;63:847–52.
39. Korenaga D, Haraguchi M, Tsujitani S, Okamura T, Tamada R, Sugimachi K. Clinicopathological features of mucosal carcinoma of the stomach with lymph node metastasis in eleven patients. Br J Surg. 1986;73:431–3.
40. Ell C, May A, Gossner L, Pech O, Günter E, Mayer G, et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology. 2000;118:670–7.
41. Tanabe S, Koizumi W, Mitomi H, Nakai H, Murakami S, Nagaba S, et al. Clinical outcome of endoscopic aspiration mucosectomy for early stage gastric cancer. Gastrointest Endosc. 2002;56:708–13.
42. Eguchi T, Gotoda T, Oda I, Hamanaka H, Hasuike N, Saito D. Is endoscopic one-piece mucosal resection essential for early gastric cancer? Dig Endosc. 2003;15: 113–6.
43. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.
44. Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3:219–25. 45. Soetikno R, Kaltenbach T, Yeh R, Gotoda T. Endoscopic mucosal resection for
early cancers of the upper gastrointestinal tract. J Clin Oncol. 2005;23:4490–8. 46. Gotoda T, Iwasaki M, Kusano C, Seewald S, Oda I. Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria. Br J Surg. 2010;97:868–71.
47. Kudo S. Endoscopic mucosal resection of flat and depressed type of early colorectal cancer. Endoscopy. 1993;25:455–61.
48. Saito Y, Fujii T, Kondo H, Mukai H, Yokota T, Kozu T, et al. Endoscopic treatment for laterally spreading tumors in the colon. Endoscopy. 2001;33:682–6. 49. Tanaka S, Haruma K, Oka S, Takahashi R, Kunihiro M, Kitadai Y, et al.
Clinico-pathologic features and endoscopic treatment of superficially spreading colo-rectal neoplasms larger than 20 mm. Gastrointest Endosc. 2001;54:62–6. 50. Kudo S, Kashida H, Tamura T, Kogure E, Imai Y, Yamano H, et al. Colonoscopic
diagnosis and management of nonpolypoid early colorectal cancer. World J Surg. 2000;24:1081–90.
51. Uraoka T, Saito Y, Matsuda T, Ikehara H, Gotoda T, Saito D, et al. Endoscopic indications for endoscopic mucosal resection of laterally spreading tumours in the colorectum. Gut. 2006;55:1592–7.
52. Walsh RM, Ackroyd FW, Shellito PC. Endoscopic resection of large sessile colorectal polyps. Gastrointest Endosc. 1992;38:303–9.
53. Uraoka T, Fujii T, Saito Y, Sumiyoshi T, Emura F, Bhandari P, et al. Effectiveness of glycerol as a submucosal injection for EMR. Gastrointest Endosc. 2005;61: 736–40.
54. Kudo S, Hirota S, Nakajima T, Hosobe S, Kusaka H, Kobayashi T, et al. Colorectal tumours and pit pattern. J Clin Pathol. 1994;47:880–5.
55. Fujii T, Hasegawa RT, Saitoh Y, Fleischer D, Saito Y, Sano Y, et al. Chromoscopy during colonoscopy. Endoscopy. 2001;33:1036–41.
56. Matsuda T, Fujii T, Saito Y, Nakajima T, Uraoka T, Kobayashi N, et al. Efficacy of the invasive/non-invasive pattern by magnifying chromoendoscopy to esti-mate the depth of invasion of early colorectal neoplasms. Am J Gastroenterol. 2008;103:2700–6.
57. Kitajima K, Fujimori T, Fujii S, Takeda J, Ohkura Y, Kawamata H, et al. Corre-lations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. J Gastroenterol. 2004;39:534–43.
58. Tanaka S, Terasaki M, Kanao H, Oka S, Chayama K. Current status and future perspectives of endoscopic submucosal dissection for colorectal tumors. Dig Endosc. 2012;24:73–9.
59. Yamamoto H, Yahagi N, Oyama T, Gotoda T, Doi T, Hirasaki S, et al. Usefulness and safety of 0.4% sodium hyaluronate solution as a submucosalfluid “cushion” in endoscopic resection for gastric neoplasms: a prospective multicenter trial. Gastrointest Endosc. 2008;67:830–9.
60. Yamamoto H, Kawata H, Sunada K, Sasaki A, Nakazawa K, Miyata T, et al. Successful en-bloc resection of large superficial tumors in the stomach and colon using sodium hyaluronate and small-caliber-tip transparent hood. Endoscopy. 2003;35:690–4.
61. Saito Y, Uraoka T, Matsuda T, Emura F, Ikehara H, Mashimo Y, et al. A pilot study to assess the safety and efficacy of carbon dioxide insufflation during colorectal endoscopic submucosal dissection with the patient under conscious sedation. Gastrointest Endosc. 2007;65:537–42.
62. Kikuchi T, Fu KI, Saito Y, Uraoka T, Fukuzawa M, Fukunaga S, et al. Trans-cutaneous monitoring of partial pressure of carbon dioxide during endoscopic submucosal dissection of early colorectal neoplasia with carbon dioxide insufflation: a prospective study. Surg Endosc. 2010;24:2231–5.
63. Saunders BP, Masaki T, Sawada T, Halligan S, Phillips RK, Muto T, et al. A preoperative comparison of Western and Oriental colonic anatomy and mesenteric attachments. Int J Colorectal Dis. 1995;10:216–21.
64. Saito Y, Uraoka T, Yamaguchi Y, Hotta K, Sakamoto N, Ikematsu H, et al. A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissections (with video). Gastrointest Endosc. 2010;72:1217–25.
65. Sakamoto T, Saito Y, Fukunaga S, Nakajima T, Matsuda T. Learning curve associated with colorectal endoscopic submucosal dissection for endoscopists experienced in gastric endoscopic submucosal dissection. Dis Colon Rectum. 2011;54:1307–12.
66. Ohata K, Ito T, Chiba H, Tsuji Y, Matsuhashi N. Effective training system in colorectal endoscopic submucosal dissection. Dig Endosc. 2012;24:84–9.
